Christopher U. Missling - 29 Jun 2021 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Role: President and CEO, Director
Signature: /s/ Christopher Missling
Issuer symbol: AVXL
Transactions as of: 29 Jun 2021
Net transactions value: -$1,273,982
Form type: 4
Filing time: 01 Jul 2021, 21:48:40 UTC
Next filing: 04 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVXL	Common Stock	Options Exercise	$68,138	+51,620	+5.1%	$1.32^*	1,069,830	29 Jun 2021	Direct
transaction	AVXL	Common Stock	Sale	$1,342,120	-51,620	-4.8%	$26.00	1,018,210	29 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVXL	Stock Option (Right to Buy)	Options Exercise	$0	-51,620	-41%	$0.000000	73,380	29 Jun 2021	Common Stock	51,620	$1.32	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options subject to this grant vested over 4 years on May 8, 2015, May 8, 2016, May 8, 2017, May 8, 2018.